Trial
NCT00783172
Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Milton S. Hershey Medical Center
Collaborators
National Institutes of Health (NIH); National Cancer Institute (NCI)
Condition
Pancreatic Cancer
Intervention
Gemcitabine
Why stopped
Problems with IRB
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-06